Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
44%
ALSO IN BBP
BBP
65
HOLDINGS
34%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 4.1% | 2.1% | 2.1% |
|
AMGEN INC | 3.7% | 2.0% | 2.0% |
|
EXELIXIS INC | 2.0% | 1.8% | 1.8% |
|
BIOGEN IDEC INC | 3.7% | 1.6% | 1.6% |
|
HALOZYME THERAPEUTICS INC | 1.6% | 2.1% | 1.6% |
FTXH Overweight Relative to BBP
|
JOHNSON & JOHNSON | 8.3% |
|
ABBVIE INC | 7.5% |
|
PFIZER INC | 7.3% |
|
MERCK & CO. INC. | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 6.1% |
|
VIATRIS, INC. | 4.1% |
|
ZOETIS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.1% |
|
ELANCO ANIMAL HEALTH, INC. | 2.7% |
|
ELI LILLY & CO | 2.7% |
FTXH Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -1.9% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
DYNAVAX TECHNOLOGIES CORP | -1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
MIRUM PHARMACEUTICALS, INC. | -1.7% |